Increased 8-hydroxy-2′-deoxyguanosine in leukocyte DNA in Leber's hereditary optic neuropathy

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 6, 2004, Pages 1688-1691

  Yen, May Yung ^a,c   Kao, Shu Huei ^a   Wang, An Guor ^a   Wei, Yau Huei ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-HYDROXY-2'-DEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; DNA; DRUG DERIVATIVE; MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ELECTROCHEMICAL DETECTION; EXTRACHROMOSOMAL INHERITANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; LEUKOCYTE; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; GENETICS; METABOLISM; MIDDLE AGED; ONSET AGE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; BIOLOGICAL MARKERS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DNA; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; OPTIC ATROPHY, HEREDITARY, LEBER; OXIDATIVE STRESS;

EID: 3042616831     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0568     Document Type: Article

References (31)

1. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
2. Yen MY, Wei YH. Leber's hereditary optic neuropathy-update review. Neuroophthalmology. 2000;26:23-34.
3. Cock HR, Cooper JM, Schapira AHV. Functional consequences of the 3460-bp mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. J Neurol Sci. 1999;165:10-17.
4. Yen MY, Lee JF, Liu JH, Wei YH. Energy charge is not decreased in lymphocytes of patients with Leber's hereditary optic neuropathy with 11778 mutation. J Neuroophthalmol. 1998;18:84-85.
5. Carelli V, Ghelli A, Ratta M, et al. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology. 1997;48:1623-1632.
6. Yen MY, Lee HC, Wang AG, Chang WL, Liu JH, Wei YH. Exclusive homoplasmic 11778 mutation in mitochondrial DNA of Chinese patients with Leber's hereditary optic neuropathy. Jpn J Ophthalmol. 1999;43:196-200.
7. Bu X, Rotter JI. A chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X-chromosome inactivation. Proc Natl Acad Sci USA. 1991;88:8198-8202.
8. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet. 19954;57:77-86.
9. Chalmers RM, Davis MB, Sweeney MG, Wood NW, Harding AE. Evidence against and X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59: 103-108.
10. Oostra RJ, Kemp S, Bolhuis PA, Bleeker-Wagemakers EM. No evidence for "skewed" inactivation of the X-chromosome as cause of Leber's hereditary optic neuropathy in female carriers. Hum Genet. 1996;97:500-505.
11. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482-1488.
12. Newman NJ. From genotype to phenotype in Leber hereditary optic neuropathy: still more questions than answers. J Neuroophthalmol. 2002;22:257-261.
13. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 2002;40:573-584.
14. Shigenaga MK, Ames BN. Assays for 8-hydroxy-2-deoxyguanosine: a biomarker of in vivo oxidative DNA damage. Free Radic Aging Degen Dis. 1991;10:211-216.
15. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997;387:147-163.
16. Helbock HJ, Beckman KB, Ames BN. 8-Hydroxydeoxyguanosine and 8-hydroxyguanosine as biomarkers of oxidative DNA damage. Methods Enzymol. 1999;300:156-165.
17. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994;91:10771-10778.
18. Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol. 1993;34:609-616.
19. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man (review). J Mol Med. 1996;74:297-312.
20. Erhola M, Yoyokuni S, Okada K, et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′- deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 1997;409:287-291.
21. Cutler GR. Free radicals and aging. In: Roy AK, Chatterjee B, eds. Molecular Basis of Aging. New York: Academic Press; 1984;263-354.
22. Asami S, Hirano T, Yamaguchi R, Tomioka Y, Itoh H, Kasai H. Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking. Cancer Res. 1996;56:2546-2549.
23. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444-445.
24. Tarng DC, Huang TP, Wei YH, et al. 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis. 2000;36:934-944.
25. Wei YH, Lee CF, Lee HC, et al. Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4977 bp-deleted mitochondrial DNA. Ann NY Acad Sci. 2001;928:97-112.
26. Wong A, Cortopassi G. mtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem Biophys Res Commun. 1997;239: 139-145.
27. Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem. 1999; 274:16188-16197.
28. Carelli V, Napoli E, Valentino L, Martinuzzi A. ROS production in cybrids carrying the three primary mutations associated with Leber's hereditary optic neuropathy. Neurology. 2002;58(suppl 3): A507.
29. Qi X, Lewin AS, Hauswirth WW, Guy J. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci. 2003;44:1088-1096.
30. Klivenyi P, Karg E, Rozsa C, et al. α-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation. J Neurol Neurosurg Psychiatry. 2001;70:359-362.
31. Wong A, Cavelier L, Collins-Schramm HE, et al. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet. 2002;11:431-438.